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1. Introduction 
It has been shown that the transport of phosphate 
(Pi) in mitochondria requires the presence of SH 
groups in the inner mitochondrial membrane [ 1,2]. 
The present study attempts o gain insight into the 
mechanism of the raitochondrial Pi transport by the 
use of SH reagents. If Pi is transported by a mobile 
carrier in the broadest sense, i.e. diffusible carrier or 
fixed carrier with conformational changes, at least 
two extreme positions can be expected where the car- 
rier is directed towards the outer or inner side of the 
membrane. Furthermore, the distribution between 
the two locations hould be variable. 
In the present case the discrimination between an 
inner and outer location of the P1 carrier has been 
indicated by comparing the effect of different SH 
reagents on the efflux and influx of Pi through the 
mitochondrial membrane. 
2. Results and discussion 
First, the effectivity of various SH reagents on the 
Pi transport in mitochondria was studied by following 
the swelling of mitochondria due to energy-indepen- 
dent osmotic equilibration i  isotonic ammonium 
phosphate buffer. Fig. 1 shows that the mercurial, 
mersalyl, inhibits transport at the lowest concentration, 
whereas the maleinimide derivative, NEM*, fully 
inhibits only at about 0.2 mM, and ASPM only at 
concentrations greater than 0.4 raM. The concentra- 
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Fig. 1. Inhibition of Pi uptake by rat liver mitochondxia n
dependence on the concentration ofvarious SH reagents. 
Indirect measurement of Pi uptake by" swelling in ammonium 
phosphate, Rat liver mitochondria (0.62 mg protein in 0.1 
rnl) are preineubated for 2 rain with different concentrations 
of mersalyl, NEM or ASPM. Then 0.1 ml mitoehondria s 
added to 1 ml of 100 mM ammonium phosphate, pH 7.2, in 
a cuvette and the swelling is followed with an Eppendorf 
Photometer at 546 nm and at 20 °. 
0 
* Abbreviations: 
NEM: N-ethyl-maleinimide; 
ASPM: N-(N-acetyl-4-sulfamoyl-phenyl)maleinimide [4] ; 
DTNB: 5,5'-dithio-bis-(2-nitrobenzoic acid) [ 5 ] ; 
EGTA: ethylene glycol bis(l~-aminoethyl)-N,N-tetra- 
acetic acid; 
FCCP: p-trifluorornethoxycarbonylcyanidephenythydra- 
zone .  
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Fig. 2. Differential effects of SH reagents on the influx (A) 
and the efflux (B) of Pi. Mitochondria (0.5 mg) are added to 
1 ml of a medium containing 0.2 M saccharose, 15 mM KCI, 
1 mM EGTA, 20 mM triethanolamine-HCl buffer, pH 7.4, and 
0.2 tag rotenone. Concentration f inhibitor: ASPM 0.125 raM, 
NEM 0.1 mM, DTNB 0.05 raM, mersalyl 0.02 raM. (A) Mito- 
chondria first incubated for 1 min with the inhibitor, then 2 
mM Pi, 5 mM succinate and 0.02 #g nonactin are added; 
(B) the inhibitor is added after swelling induced by the same 
conditions as in A. After 1 min incubation, 0.5 #M FCCP is 
added. 
Thus, under the same conditions and the same con- 
centrations of ASPM, where the influx of Pi is fully 
inhibited, the effiux remains fully active. At a higher 
concentration f ASPM, the efflux can be partially 
inhibited. 
Another method for following the inhibition of Pi 
uptake is to generate Pi inside by an FCCP-induced 
ATP-hydrolysis. The inhibition by mersalyl causes an 
accumulation of Pi and therefore a swelling, as shown 
by Tyler [2]. This i,s confirmed in fig. 3, where NEM 
as well as mersalyl is able to produce swelling. In the 
presence of ASPM and also DTNB at the same con- 
centrations as in fig. 2, no swelling is observed. This 
indicates that ASPM and DTNB do not inhibit the 
efflux of Pi, as shown in the previous experiments. 
The possible xplanation that ASPM inhibits the 
ATPase can be excluded by the subsequent addition 
of mersalyl which then still induces welling due to 
the Pi accumulation from ATP hydrolysis. 
These results may be interpreted to show that the 
carrier for Pi has at least two locations in the mem- 
brane: position 1 is accessible to all four SH reagents, 
position 2 is inaccessible to ASPM and DTNB, but 
not to NEM and mersalyl. Since it is feasible that 
ASPM and DTNB do not easily penetrate the mem- 
brane, one can further specify that in position 1 the 
SH groups are directed to the outside and in position 
2 to the inside. 
tion dependence is closely connected to the reaction 
rates of these reagents. ASPM reacts lowest. This can 
be explained in part by the relative impermeability of
ASP [3] which forms the basis of the present studies. 
In fig. 2 the effects of various SH reagents on the 
uptake and release of Pi are compared by following 
the energy-dependent swelling and contraction of 
mitochondria atlow concentrations of Pi" Fig. 2A 
shows that the swelling, i.e. uptake of Pi initiated by 
addition of nonactin is fully inhibited by various 
SH reagents including ASPM. In these experiments 
the proportion of ASPM to protein is higher than in 
those of fig. 1. The release of Pi as followed by the 
contraction of the mitochondria n fig. 2B is complete- 
ly inhibited by mersalyl, partially by NEM and to a 
lesser degree by DTNB, whereas ASPM does not inhibit. 
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Fig. 3. Comparative action of the SH reagents on the efflux 
of Pi produced by a FCCP-induced hydrolysis. Mitochondria 
(0.5 mg) are suspended in 1 ml of medium as in fi~. 2. 
SH reagent is added at the same concentrations as in fig. 2. 
Then 0.5 tam FCCP and 1 mM ATP are added. 
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In principle this could be rationalized by a mobile or 
reoriented carrier in which the binding sites and SH 
groups can be distributed to the inner and outer 
locations to a varying degree. In the experiment of Pi 
uptake (fig. 2A) the SH groups are located mainly 
to the outside and accessible to ASPM. In the experi- 
ment of Pi release (fig. 2B) the SH groups are located 
to the inside and inaccessible to ASPM. 
The inhibition by ASPM only of the uptake and not 
of the release ofP  i might be considered to contradict 
the principles of thermodynamics unless Pi transport 
in the two directions is catalyzed by different rans- 
port mechanisms. However, it should be considered 
that for the two directions the conditions are dif- 
ferent. As a result an unequal in and out distribution 
of the same carrier can be expected which is different 
for both directions. 
In the case when the same carrier catalyzes transport 
in both directions, if one direction of transport is 
inhibited, the other direction should also be abolished. 
This can in fact be demonstrated in the experiments 
shown in fig. 4, where first the uptake of Pi (accord- 
ing to conditions of fig. 2) is inhibited by ASPM. If 
now the efflux is assayed with ATP + FCCP, swelling 
is observed as a result of the inhibition of the Pi 
release. This rate is nearly the same as with mersalyl 
which completely inhibits the Pi efflux (cf. fig. 3). 
Once ASPM has inhibited uptake, it also inhibits 
efflux. It can be concluded that the same carrier 
catalyzes uptake and release of Pi and that an asym- 
metric distribution of the SH groups may cause a 
different degree of inhibition in both directions. 
The reactivity of the carrier with ASPM can be 
expected to depend on its steady state distribution at 
the outside. This is influenced by the presence of 
exogenous Pi, as demonstrated by the experiment in
fig. 5. First ASPM is allowed to react with the carrier, 
with or without the presence of Pi, and then the un- 
reacted ASPM is removed by cysteine in order to 
prevent further eaction of ASPM during Pi uptake. 
Subsequently, the remaining activity of the carrier is 
FCCP+ATP 
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Fig. 4. Demonstration that inhibition by ASPM of Pi influx 
also gives inhibition ofP i efflux. (A and B) under similar 
conditions as in fig. 3. ASPM cannot inhibit the release of Pi; 
(C) before FCCP and ATP, 2 mM Pi, 5 mM succinate and 
0.02 pg nonactin are added. 
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Fig. 5. Dependence on external Pi of the inhibition by ASPM. 
The conditions are the same as in fig. 2A, but cysteine is ad- 
ded to eliminate free ASPM which has not reacted. 0.7 mg 
protein, 0.2 mM ASPM, 1 min incubation. 2 mM Pi, 5 mM 
succinate 0.02 ~g nonactin, 1mM cysteine. 
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assayed by the Pi influx. As shown in fig. 5A, the 
inhibition by ASPM of the Pi influx is not abolished 
by addition of cysteine. When free ASPM is removed 
by cysteine before the addition of Pi (fig. 5C), the Pi 
uptake is still active to about 60% as compared to the 
uptake without ASPM (fig. 5D). In the opposite case, 
when ASPM can react in the presence ofP i (fig. 5B) and 
the cysteine is added, only 30% of the activity 
remains. In order to obtain nearly complete in- 
hibition, ASPM must be present during the Pi influx, 
as shown in 1figs. 5A and 4C. 
These results how that the position of the SH 
group of the Pi carrier, as assayed by the accessibility 
to ASPM, varies depending on several parameters. 
In the absence of added Pi, the carrier SH groups are 
directed mainly to the inside. Therefore an imper- 
meable SH reagent such as ASPM cannot react with 
the SH group protected by the membrane barrier. On 
addition of Pi, the carriers are distributed at least 
partially towards the outside, so that ASPM can now 
react with a larger ratio of the SH groups. During the 
active Pi influx, apparently all the SH groups of the Pi 
carrier become available at the external position for 
reaction with ASPM. This situation may be summarized 
briefly as follows: 
[Pi]e = 0 Ce/C i = 0, ASPM noninhibiting 
[Pi] e > 0 Ce/C i > O, ASPM inhibiting 
This interpretation of the results indicates that the 
Pi carrier can be regarded as a mobile carrier which can 
move its reactive site during the transport to both sides 
of the inner mitochondrial membrane. In the steady 
state, the distribution of the carrier at the inner or 
outer localization appears to vary according to the 
direction of the Pi flux. 
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